Latest Product Pipeline News

Pilot Energy confirms regulatory compliance and operational progress at the Head Field, advancing the repurposing of Cliff Oil infrastructure into a carbon storage facility as part of the Mid West Clean Energy Project.

EVE Health Group has executed a binding agreement to acquire Australian biotech Nextract, targeting rapid-onset treatments in the $16 billion global erectile dysfunction and dysmenorrhea markets. The acquisition, supported by a $1.5 million capital raise and share consolidation, marks a strategic shift into regulated pharmaceutical channels.

Optiscan Imaging Ltd has revealed its next-generation InForm™ pathology imaging device and strengthened its executive team, while reporting a robust cash position supported by a $1.775 million R&D tax refund for the quarter ended 31 March 2025.

Universal Biosensors reported a 28% increase in customer receipts to $1.6 million for Q1 2025, alongside improved cash flow and plans for a new product launch later this year.

Orbital Corporation Ltd reported a positive operating cash flow of $0.7 million for Q1 2025, supported by a solid order book and ongoing development of a new larger capacity engine prototype.

Knosys Limited reports a record Annual Recurring Revenue run rate of $9.8 million, driven by strong enterprise renewals and new customer wins, alongside the launch of its next-generation Libero library app and upgraded LMS.

AVITA Medical reported a robust 30% increase in Q4 2024 commercial revenue alongside key FDA clearances, setting the stage for ambitious growth in 2025.

Micro-X Ltd has launched the retail component of its $6 million capital raising, offering eligible shareholders the chance to buy new shares at 7 cents each, aiming to raise $2.7 million by late February 2025.

BTC Health has transformed its decade-long license agreement with Arna Pharma into an indefinite partnership, gaining royalties from Singapore and Malaysia sales and first rights to new pharmaceutical products in Australia and New Zealand.

Acrux Limited announces the retirement of CEO Michael Kotsanis after more than 10 years at the helm, with a search underway for his successor to lead the next phase of growth.

Catalyst Metals Limited is ramping up exploration in the historically underexplored Plutonic Gold Belt, aiming to boost annual gold production from 110,000 to 200,000 ounces. With a robust cash position and a $40 million drilling program underway, the company is poised to unlock significant new resources.

Atomos Limited reported a 7% increase in Q2 FY25 sales driven by its core Shinobi II product, but faced margin pressures due to discounting and competitive pricing. The company is finalizing a cost restructure and reviewing funding options to support future growth.